Skip to content

Shares (Basic) at other companies

Incyte logo
IncyteINCY
199.3M+2.9%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
192.5M+0.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
45.1M+32.9%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%
Nuvation Bio logo
Nuvation BioNUVB
347.3M+2.6%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.81B+318%
Enterprise value$1.73B+397%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s shares (basic)?
Tyra Biosciences, Inc. (TYRA) reported shares (basic) of 61.7M in Q1 2026.
How has Tyra Biosciences, Inc.'s shares (basic) changed year-over-year?
Tyra Biosciences, Inc.'s shares (basic) increased by 4.1% year-over-year, from 59.3M to 61.7M.
What is the long-term trend for Tyra Biosciences, Inc.'s shares (basic)?
Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s shares (basic) has grown at a 12.5% compound annual growth rate (CAGR), from 167.2M to 238.2M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.